Clinical Trial Update: Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes a response-adaptive treatment approach for untreated locoregional HPV-negative head and neck cancer and is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: University of Chicago | Conditions: Head and Neck Cancer, HPV | Phase 2 | Status: RECRUITING